Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials
2014 · Drug Safety · 41 citations
https://doi.org/10.1007/s40264-014-0183-6
M
Markku Pasanen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
180
Papers
6.4K
Citations
41
h-index
112
i10-index
Markku Pasanen is an academic researcher from University of Eastern Finland. The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Drug-Induced Hepatotoxicity and Protection & Eicosanoids and Hypertension Pharmacology. The author has an h-index of 41, co-authored 153 publications.
ORCID: 0000-0002-2557-9034Papers by this author
worksCytotoxicity of Oxycodone and Morphine in Human Neuroblastoma and Mouse Motoneuronal Cells: A Comparative Approach
2016 · Drugs in R&D · 20 citations
https://doi.org/10.1007/s40268-016-0125-0
Longitudinal Analyses of Diet Quality and Maternal Depressive Symptoms During Pregnancy: The Kuopio Birth Cohort Study
2022 · Journal of the Academy of Nutrition and Dietetics · 13 citations
https://doi.org/10.1016/j.jand.2022.05.018
Aryl hydrocarbon receptor (AhR) agonist β-naphthoflavone regulated gene networks in human primary trophoblasts
2020 · Reproductive Toxicology · 7 citations
https://doi.org/10.1016/j.reprotox.2020.08.008
Aflatoxin B1 targeted gene expression profiles in human placental primary trophoblast cells
2022 · Current Research in Toxicology · 3 citations
https://doi.org/10.1016/j.crtox.2022.100082
Author’s Reply to Parsons: “Cytotoxicity of Oxycodone and Morphine in Human Neuroblastoma and Mouse Motoneuronal Cells: A Comparative Approach”
2016 · Drugs in R&D · 0 citations
https://doi.org/10.1007/s40268-016-0136-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat